Cardiovascular Mapping in Cirrhosis From the Compensated Stage to Hepatorenal Syndrome: A Magnetic Resonance Study

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Cardiovascular Mapping in Cirrhosis From the Compensated Stage to Hepatorenal Syndrome : A Magnetic Resonance Study. / Danielsen, Karen Vagner; Wiese, Signe; Busk, Troels; Nabilou, Puria; Kronborg, Thit Mynster; Petersen, Claus Leth; Hove, Jens Dahlgaard; Møller, Søren; Bendtsen, Flemming.

I: American Journal of Gastroenterology, Bind 117, Nr. 8, 2022, s. 1269-1278.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Danielsen, KV, Wiese, S, Busk, T, Nabilou, P, Kronborg, TM, Petersen, CL, Hove, JD, Møller, S & Bendtsen, F 2022, 'Cardiovascular Mapping in Cirrhosis From the Compensated Stage to Hepatorenal Syndrome: A Magnetic Resonance Study', American Journal of Gastroenterology, bind 117, nr. 8, s. 1269-1278. https://doi.org/10.14309/ajg.0000000000001847

APA

Danielsen, K. V., Wiese, S., Busk, T., Nabilou, P., Kronborg, T. M., Petersen, C. L., Hove, J. D., Møller, S., & Bendtsen, F. (2022). Cardiovascular Mapping in Cirrhosis From the Compensated Stage to Hepatorenal Syndrome: A Magnetic Resonance Study. American Journal of Gastroenterology, 117(8), 1269-1278. https://doi.org/10.14309/ajg.0000000000001847

Vancouver

Danielsen KV, Wiese S, Busk T, Nabilou P, Kronborg TM, Petersen CL o.a. Cardiovascular Mapping in Cirrhosis From the Compensated Stage to Hepatorenal Syndrome: A Magnetic Resonance Study. American Journal of Gastroenterology. 2022;117(8):1269-1278. https://doi.org/10.14309/ajg.0000000000001847

Author

Danielsen, Karen Vagner ; Wiese, Signe ; Busk, Troels ; Nabilou, Puria ; Kronborg, Thit Mynster ; Petersen, Claus Leth ; Hove, Jens Dahlgaard ; Møller, Søren ; Bendtsen, Flemming. / Cardiovascular Mapping in Cirrhosis From the Compensated Stage to Hepatorenal Syndrome : A Magnetic Resonance Study. I: American Journal of Gastroenterology. 2022 ; Bind 117, Nr. 8. s. 1269-1278.

Bibtex

@article{f8f2beab85fb482f8769f41dcd0b4800,
title = "Cardiovascular Mapping in Cirrhosis From the Compensated Stage to Hepatorenal Syndrome: A Magnetic Resonance Study",
abstract = "INTRODUCTION:Arterial vasodilation and hyperdynamic circulation are considered hallmarks of the pathophysiological mechanisms of decompensation in cirrhosis. However, detailed characterization of peripheral, splanchnic, renal, and cardiac hemodynamic have not previously been published in a spectrum from healthy stage to advanced decompensated liver disease with hepatorenal syndrome-acute kidney injury (HRS-AKI).METHODS:We included 87 patients with cirrhosis and 27 healthy controls in this prospective cohort study. The population comprised patients with compensated cirrhosis (n = 27) and decompensated cirrhosis (n = 60); patients with decompensated cirrhosis were further separated into subsets of responsive ascites (33), refractory ascites (n = 16), and HRS-AKI (n = 11). We measured portal pressure and assessed regional blood flow by magnetic resonance imaging.RESULTS:Patients with compensated cirrhosis experienced higher azygos venous flow and higher hepatic artery flow fraction of cardiac index than controls (P < 0.01), but other flow parameters were not significantly different. Patients with decompensated cirrhosis experienced significantly higher cardiac index (P < 0.01), higher superior mesenteric artery flow (P = 0.01), and lower systemic vascular resistance (P < 0.001) compared with patients with compensated cirrhosis. Patients with HRS-AKI had the highest cardiac output and lowest renal flow of all groups (P < 0.01 and P = 0.02, respectively). Associations of single hemodynamic parameters were stronger with model for end-stage liver disease than with portal pressure.DISCUSSION:The regional cardiocirculatory changes seem closely linked to clinical symptoms with 3 distinguished hemodynamic stages from compensated to decompensated cirrhosis and, finally, to HRS-AKI. The attenuated renal perfusion despite high cardiac output in patients with HRS-AKI challenges the prevailing pathophysiological hypothesis of cardiac dysfunction as a causal factor in HRS-AKI. Finally, magnetic resonance imaging seems an accurate and reliable noninvasive method to assess hemodynamics and has potential as a diagnostic tool in patients with cirrhosis.",
author = "Danielsen, {Karen Vagner} and Signe Wiese and Troels Busk and Puria Nabilou and Kronborg, {Thit Mynster} and Petersen, {Claus Leth} and Hove, {Jens Dahlgaard} and S{\o}ren M{\o}ller and Flemming Bendtsen",
note = "Publisher Copyright: {\textcopyright} 2022 Wolters Kluwer Health. All rights reserved.",
year = "2022",
doi = "10.14309/ajg.0000000000001847",
language = "English",
volume = "117",
pages = "1269--1278",
journal = "The American Journal of Gastroenterology",
issn = "0002-9270",
publisher = "nature publishing group",
number = "8",

}

RIS

TY - JOUR

T1 - Cardiovascular Mapping in Cirrhosis From the Compensated Stage to Hepatorenal Syndrome

T2 - A Magnetic Resonance Study

AU - Danielsen, Karen Vagner

AU - Wiese, Signe

AU - Busk, Troels

AU - Nabilou, Puria

AU - Kronborg, Thit Mynster

AU - Petersen, Claus Leth

AU - Hove, Jens Dahlgaard

AU - Møller, Søren

AU - Bendtsen, Flemming

N1 - Publisher Copyright: © 2022 Wolters Kluwer Health. All rights reserved.

PY - 2022

Y1 - 2022

N2 - INTRODUCTION:Arterial vasodilation and hyperdynamic circulation are considered hallmarks of the pathophysiological mechanisms of decompensation in cirrhosis. However, detailed characterization of peripheral, splanchnic, renal, and cardiac hemodynamic have not previously been published in a spectrum from healthy stage to advanced decompensated liver disease with hepatorenal syndrome-acute kidney injury (HRS-AKI).METHODS:We included 87 patients with cirrhosis and 27 healthy controls in this prospective cohort study. The population comprised patients with compensated cirrhosis (n = 27) and decompensated cirrhosis (n = 60); patients with decompensated cirrhosis were further separated into subsets of responsive ascites (33), refractory ascites (n = 16), and HRS-AKI (n = 11). We measured portal pressure and assessed regional blood flow by magnetic resonance imaging.RESULTS:Patients with compensated cirrhosis experienced higher azygos venous flow and higher hepatic artery flow fraction of cardiac index than controls (P < 0.01), but other flow parameters were not significantly different. Patients with decompensated cirrhosis experienced significantly higher cardiac index (P < 0.01), higher superior mesenteric artery flow (P = 0.01), and lower systemic vascular resistance (P < 0.001) compared with patients with compensated cirrhosis. Patients with HRS-AKI had the highest cardiac output and lowest renal flow of all groups (P < 0.01 and P = 0.02, respectively). Associations of single hemodynamic parameters were stronger with model for end-stage liver disease than with portal pressure.DISCUSSION:The regional cardiocirculatory changes seem closely linked to clinical symptoms with 3 distinguished hemodynamic stages from compensated to decompensated cirrhosis and, finally, to HRS-AKI. The attenuated renal perfusion despite high cardiac output in patients with HRS-AKI challenges the prevailing pathophysiological hypothesis of cardiac dysfunction as a causal factor in HRS-AKI. Finally, magnetic resonance imaging seems an accurate and reliable noninvasive method to assess hemodynamics and has potential as a diagnostic tool in patients with cirrhosis.

AB - INTRODUCTION:Arterial vasodilation and hyperdynamic circulation are considered hallmarks of the pathophysiological mechanisms of decompensation in cirrhosis. However, detailed characterization of peripheral, splanchnic, renal, and cardiac hemodynamic have not previously been published in a spectrum from healthy stage to advanced decompensated liver disease with hepatorenal syndrome-acute kidney injury (HRS-AKI).METHODS:We included 87 patients with cirrhosis and 27 healthy controls in this prospective cohort study. The population comprised patients with compensated cirrhosis (n = 27) and decompensated cirrhosis (n = 60); patients with decompensated cirrhosis were further separated into subsets of responsive ascites (33), refractory ascites (n = 16), and HRS-AKI (n = 11). We measured portal pressure and assessed regional blood flow by magnetic resonance imaging.RESULTS:Patients with compensated cirrhosis experienced higher azygos venous flow and higher hepatic artery flow fraction of cardiac index than controls (P < 0.01), but other flow parameters were not significantly different. Patients with decompensated cirrhosis experienced significantly higher cardiac index (P < 0.01), higher superior mesenteric artery flow (P = 0.01), and lower systemic vascular resistance (P < 0.001) compared with patients with compensated cirrhosis. Patients with HRS-AKI had the highest cardiac output and lowest renal flow of all groups (P < 0.01 and P = 0.02, respectively). Associations of single hemodynamic parameters were stronger with model for end-stage liver disease than with portal pressure.DISCUSSION:The regional cardiocirculatory changes seem closely linked to clinical symptoms with 3 distinguished hemodynamic stages from compensated to decompensated cirrhosis and, finally, to HRS-AKI. The attenuated renal perfusion despite high cardiac output in patients with HRS-AKI challenges the prevailing pathophysiological hypothesis of cardiac dysfunction as a causal factor in HRS-AKI. Finally, magnetic resonance imaging seems an accurate and reliable noninvasive method to assess hemodynamics and has potential as a diagnostic tool in patients with cirrhosis.

U2 - 10.14309/ajg.0000000000001847

DO - 10.14309/ajg.0000000000001847

M3 - Journal article

C2 - 35916685

AN - SCOPUS:85135597620

VL - 117

SP - 1269

EP - 1278

JO - The American Journal of Gastroenterology

JF - The American Journal of Gastroenterology

SN - 0002-9270

IS - 8

ER -

ID: 323847109